- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
32 result(s) found for: Female Factor Infertility.
Displaying page 1 of 2.
EudraCT Number: 2016-004302-33 | Sponsor Protocol Number: TESTOPRIM | Start Date*: 2017-04-07 | |||||||||||
Sponsor Name:INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE | |||||||||||||
Full Title: Clinical effect of follicular preparation with testosterone in poor ovarian response: a randomized controlled clinical trial (TESTOPRIM) | |||||||||||||
Medical condition: Infertility with Poor Ovarian Response | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003879-42 | Sponsor Protocol Number: 2021/ABM/03/00006 | Start Date*: 2023-04-12 | ||||||||||||||||
Sponsor Name:Medical Univeristy of Bialystok | ||||||||||||||||||
Full Title: A randomized, controlled, double-blind clinical trial evaluating the effect of METformin treatment on endometrial function in women diagnosed with Idiopathic Infertility | ||||||||||||||||||
Medical condition: Potential causes of idiopathic infertility include in particular: abnormal function of the endometrium, including implantation disorders and immunological abnormalities, genetic abnormalities and t... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: PL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003810-13 | Sponsor Protocol Number: 000289 | Start Date*: 2018-05-21 | |||||||||||||||||||||||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||||||||||||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, parallel-group, dose-range trial to investigate the efficacy and safety of FE 999302 as add-on treatment to follitropin delta (REKOVELLE) in women un... | |||||||||||||||||||||||||||||||||
Medical condition: Women diagnosed with tubal infertility or unexplained infertility or endometriosis stage I/II or having partners diagnosed with male factor infertility, eligible for IVF and/or ICSI. | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: CZ (Completed) DK (Completed) BE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-000753-80 | Sponsor Protocol Number: 000298 | Start Date*: 2022-08-04 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women underg... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001785-38 | Sponsor Protocol Number: 000401 | Start Date*: 2021-10-05 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response of a starting dose of 15 µg follitropin delta (REKOVELLE) to a starting do... | |||||||||||||
Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Completed) FR (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001708-39 | Sponsor Protocol Number: S54224 | Start Date*: 2012-06-07 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Prospective randomized trial concerning three different stimulation methods in IVF/ICSI treatment in poor responders | ||||||||||||||||||
Medical condition: Subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002783-40 | Sponsor Protocol Number: 000304 | Start Date*: 2019-07-04 | |||||||||||||||||||||||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||||||||||||||||||||||
Full Title: A randomised, controlled, open label, parallel group, multicentre trial comparing the efficacy and safety of individualised FE 999049 (follitropin delta) dosing, using a long GnRH agonist protocol ... | |||||||||||||||||||||||||||||||||
Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: AT (Completed) DK (Completed) NO (Completed) NL (Completed) IT (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020240-35 | Sponsor Protocol Number: 2010-020240-35 | Start Date*: 2010-07-09 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | ||||||||||||||||||
Full Title: Significance of the FSH receptor polymorphism p.N680S for the efficacy of FSH therapy of idiopathic male infertility: a pharmacogenetic approach. | ||||||||||||||||||
Medical condition: Idiopathic male infertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: IT (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003788-67 | Sponsor Protocol Number: FS1306 | Start Date*: 2014-01-29 | |||||||||||
Sponsor Name:Watson Laboratories, Inc. - A subsidiary of Actavis, Inc. | |||||||||||||
Full Title: A Randomised, Parallel Group, Assessor-Blind, Multicentre Study to Compare the Safety and Efficacy of Watson rhFSH with Follitropin Alfa (GONAL-f) in Stimulating Multiple Follicular Development in ... | |||||||||||||
Medical condition: Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Prematurely Ended) ES (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001137-41 | Sponsor Protocol Number: 666 | Start Date*: 2018-06-26 |
Sponsor Name:Hvidovre Hospital. Dep of Respiratory Medicine | ||
Full Title: Use of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma and infertility will be treated three times with weight and IgE balanced dosis at the sixth day o... | ||
Medical condition: infertility within female asthma patients as a result of systemic inflamation. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001034-18 | Sponsor Protocol Number: NL43131-018-13 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:AMC Amsterdam | |||||||||||||
Full Title: Super ovulation in intrauterine insemination: FSH or Clomifene citrate | |||||||||||||
Medical condition: Women diagnosed with unexplained subfertility or mild male factor subfertility with an indication for intra uterine insemination | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001590-32 | Sponsor Protocol Number: MMC-2016-01 | Start Date*: 2018-04-19 | |||||||||||
Sponsor Name:Manuel Macía Cortiñas | |||||||||||||
Full Title: Comparison of two protocols of controlled ovarian stimulation with highly purified menotropin in low-responder patients according to Bologna criteria treated in Spanish public hospitals. | |||||||||||||
Medical condition: PRIMARY INFERTILITY | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000633-36 | Sponsor Protocol Number: 000009 | Start Date*: 2011-08-09 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multinational, multicentre trial assessing the dose-response relationship of FE 999049 in controlled ovarian stimulation in women undergoi... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) BE (Completed) CZ (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001669-17 | Sponsor Protocol Number: 000004 | Start Date*: 2013-09-17 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stim... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) PL (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005452-24 | Sponsor Protocol Number: KvL | Start Date*: 2008-10-30 | |||||||||||
Sponsor Name:Fertilitetsklinikken, Afsnit 455, Gynækologisk-Obstetrisk Afdeling, Hvidovre Hospital | |||||||||||||
Full Title: Kort versus lang reagensglasbehandling. En prospektiv, konsekutiv og randomiseret sammenlignende undersøgelse. | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005571-14 | Sponsor Protocol Number: TIMING | Start Date*: 2013-08-02 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
Full Title: CLINICAL TRIAL, SINGLE BLIND, RANDOMIZED, CONTROLLED PROSPECTIVE EVALUATION FOR OPTIMUM TIME INTERVAL BETWEEN ACETATE ADMINISTRATION AND PUNCTURE TRIPTORELIN FOLLICULAR IN IVF TREATMENT | ||
Medical condition: INFERTILITY | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003484-56 | Sponsor Protocol Number: BOLDOS-18 | Start Date*: 2019-12-26 | |||||||||||
Sponsor Name:Miguel Caballero Campo | |||||||||||||
Full Title: Efficacy of corifolitropin alfa in double ovarian stimulation compared with two conventional ovarian stimulation cycles for embryo accmulation in low responder patients. Multicenter randomized cont... | |||||||||||||
Medical condition: Infertility in patients requiring in vitro fertilization treatment with poor ovarian response profile, defined by Bologna Criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004669-28 | Sponsor Protocol Number: 1704-GINFER-01-BMEC | Start Date*: 2019-04-04 |
Sponsor Name:CENTRO GINECOLOGICO GINFER | ||
Full Title: A clinical tryal of the utility of ozone in patients with implantation failures | ||
Medical condition: Evaluate the action of ozone in the regulation, concentration and activation of uterine NK. Quantify the cytokines present in the uterine decidua pre and post ozone exposure in the uterus. Quantify... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001105-81 | Sponsor Protocol Number: ACT-CYC-300-2013-01 | Start Date*: 2013-07-31 |
Sponsor Name:Actavis Group PTC ehf. | ||
Full Title: Randomized Clinical Trial to Compare the Pregnancy Rates of Vaginally Applied Cyclogest® Pessary and Crinone® 8% Gel After In-vitro Fertilization | ||
Medical condition: Luteal phase support after IVF | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: HU (Completed) BE (Completed) BG (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000993-32 | Sponsor Protocol Number: S55300 | Start Date*: 2013-05-07 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Does prolonged GnRH downregulation prior to ART improve the clinical pregnancy rate in postoperative endometriosis patients? A RCT | ||||||||||||||||||
Medical condition: endometriosis, subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
